Non-Dilutive Grant Funding Archives

Tevogen Bio to Receive $8M of Non-Dilutive Grant Funding, Reiterates Efficient Operations

Insider Brief PRESS RELEASE — Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech, announced in January 2025, it received $2 million on non-dilutive grant funding from KRHP

5 Mar 2025 · 3 min read

Non-Dilutive Grant Funding

Tevogen Bio to Receive $8M of Non-Dilutive Grant Funding, Reiterates Efficient Operations

Trending today

Tenstorrent Announces a $1.5B Series E at a $6.2B Valuation

Anthropic Details AI-Driven Workforce Shift and Commits 5% of Shares to Public Benefit Fund as Replit Moves Default to OpenAI

Meta Drops Commercial Terms Language That Sparked AI Training and Scraping Concerns

Otter.ai Raises $320M From General Catalyst’s Customer Value Fund to Expand Enterprise AI

Fragment Raises $12M Series A to Turn Agents into Financial Operators

Non-Dilutive Grant Funding

Tevogen Bio to Receive $8M of Non-Dilutive Grant Funding, Reiterates Efficient Operations

Trending today

Tenstorrent Announces a $1.5B Series E at a $6.2B Valuation

Anthropic Details AI-Driven Workforce Shift and Commits 5% of Shares to Public Benefit Fund as Replit Moves Default to OpenAI

Meta Drops Commercial Terms Language That Sparked AI Training and Scraping Concerns

Otter.ai Raises $320M From General Catalyst’s Customer Value Fund to Expand Enterprise AI

Fragment Raises $12M Series A to Turn Agents into Financial Operators

The AI economy, every weekday morning